Analysis of pediatric adverse reactions to transfusions

Transfusion

Volumn 58, Issue 1, 2018, Pages 60-69

  Vossoughi, Sarah ^a,b   Perez, Gabriela ^c   Whitaker, Barbee I ^c   Fung, Mark K ^d   Stotler, Brie ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c AABB   (United States)

^d FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC REACTION; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEVER; GROUPS BY AGE; HUMAN; HYPERVOLEMIA; HYPOTENSION; INFANT; INFECTION; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; RETROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY; TRANSFUSION TRANSMITTED INFECTION; AGE; AGED; BLOOD SAFETY; CAUSALITY; CLINICAL TRIAL; FACTUAL DATABASE; FEMALE; HOSPITAL; HYPERSENSITIVITY; MALE; MIDDLE AGED; MULTICENTER STUDY; SHOCK; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD SAFETY; CAUSALITY; CHILD; DATABASES, FACTUAL; DYSPNEA; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; HYPERSENSITIVITY; HYPOTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SHOCK; TRANSFUSION REACTION; UNITED STATES;

EID: 85040170888     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14359     Document Type: Article

References (20)

1. Klassen TP, Hartling L, Craig JC, et al. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med 2008;e172:1180-2.
2. New HV, Berryman J, Bolton-Maggs PH, et al. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol 2016;175:784-828.
3. Peltoniemi OM, Rautiainen P, Kataja J, et al. Pediatric intensive care in PICUs and adult ICUs: a 2-year cohort study in Finland. Pediatr Crit Care Med 2016;17:e43-9.
4. Adeli K, Higgins V, Nieuwesteeg M, et al. Biochemical marker reference values across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin Chem 2015;61:1049-62.
5. Oakley FD, Woods M, Arnold S, et al. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products. Transfusion 2015;55:563-70.
6. OASH regional offices [Internet]. Washington (DC): U.S. Department of Health & Human Services [cited 2017 Aug 8]. Available from: https://www.hhs.gov/ash/about-ash/regional-offices/index.html.
7. U.S. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) Manual: Biovigilance Component v2.2. Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases [cited 2016 Sep 30]. Available from: http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf
8. Hendrickson JE, Josephson CD. Neonatal and pediatric transfusion medicine. In: Shaz BH, Hillyer CD, Roshal M, Abrams CS, editors, Transfusion medicine and hemostasis: clinical and laboratory aspects. 2nd ed. Waltham (MA): Elsevier; 2013. p. 301-5.
9. Josephson CD, Meyer E. Neonatal and pediatric transfusion practice. In: Fung MK, Grossman BJ, Hillyer CD, Westhoff CM, editors. Technical manual. 18th ed. Bethesda (MD): AABB; 2014. p. 571-97.
10. Whitaker BI, Rajbhandary S, Harris A. The 2013 AABB blood collection, utilization, and patient blood management survey report [Internet]. Bethesda: AABB; 2015 [cited 2017 May 4]. Available from: http://www.aabb.org/research/hemovigilance/bloodsurvey/Docs/2013-AABB-Blood-Survey-Report.pdf.
11. Haass K. National Healthcare Safety Network (NHSN) Hemovigilance Module: accomplishments. Oral presentation at AABB Hemovigilance Symposium, Atlanta, GA, Feb 2017.
12. Thomas D, Bolton-Maggs P, Watt A, et al. Annual SHOT report 2015. Manchester: SHOT Office; 2016 [cited 2017 Jul 4]. Available from: https://www.shotuk.org/wp-content/uploads/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked-1.pdf
13. Steinsvåg CT, Espinosa A, Flesland Ø. Eight years with haemovigilance in Norway. What have we learnt? Transfus Apher Sci 2013;49:548-52.
14. Danish Registry of Transfusion Risks. Annual DART report - 2014 summary [Internet]. Aarhus: Division of the Danish Society of Clinical Immunology (DSKI) [cited 2017 Jul 20]. Available from: http://dski.dk/files/English-summary-2014.pdf
15. The TRIP Foundation of Transfusion and Transplantation Reactions in Patients. TRIP report 2015: hemovigilance extended version. Leiden: TRIP National Agency for Hemorrhoids and Biovigilance; 2017 [cited 2017 Jul 20]. Available from: https://www.tripnet.nl/pages/en/documents/Trip.HEMO_ENG_19.04.2017def.pdf
16. Harvey AR, Basavaraju SV, Chung KW, et al. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010-2012. Transfusion 2015;55:709-18.
17. Sanders RP, Maddirala SD, Geiger TL, et al. Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 2005;130:781-7.
18. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-92.
19. Osby M, Shulman I. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190-3.
20. O'Suoji C, Liem RI, Mack AK, et al. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer 2013;60:1487-91.